Global Alzheimer’s Therapeutics Market Research Report 2024(Status and Outlook)

Global Alzheimer’s Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The Global Alzheimer’s Therapeutics Market Size was estimated at USD 4907.31 million in 2023 and is projected to reach USD 6843.74 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.

This report provides a deep insight into the global Alzheimer’s Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alzheimer’s Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alzheimer’s Therapeutics market in any manner.

Global Alzheimer’s Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

Merck &

Novartis AG

Eisai

H. Lundbeck A/S

AC Immune

TauRx Pharmaceuticals

Actavis plc.

Forest Laboratories

Teva Pharmaceuticals Industries

Janssen Pharmaceutical

GE healthcare

Eli Lilly And Company

DiaGenic ASA

VTV Therapeutics

Hoffman-La Roche

AstraZeneca

Daiichi Sankyo Company

Market Segmentation (by Type)

Donepezil

Memantine

Rivastigmine

Market Segmentation (by Application)

Early to Moderate Stages

Moderate to Severe Stages

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Alzheimer’s Therapeutics Market

Overview of the regional outlook of the Alzheimer’s Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alzheimer’s Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Alzheimer’s Therapeutics
1.2 Key Market Segments
1.2.1 Alzheimer’s Therapeutics Segment by Type
1.2.2 Alzheimer’s Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Alzheimer’s Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Alzheimer’s Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Alzheimer’s Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Alzheimer’s Therapeutics Market Competitive Landscape
3.1 Global Alzheimer’s Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Alzheimer’s Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Alzheimer’s Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alzheimer’s Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alzheimer’s Therapeutics Sales Sites, Area Served, Product Type
3.6 Alzheimer’s Therapeutics Market Competitive Situation and Trends
3.6.1 Alzheimer’s Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alzheimer’s Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Alzheimer’s Therapeutics Industry Chain Analysis
4.1 Alzheimer’s Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Alzheimer’s Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Alzheimer’s Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alzheimer’s Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Alzheimer’s Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Alzheimer’s Therapeutics Price by Type (2019-2024)
7 Alzheimer’s Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alzheimer’s Therapeutics Market Sales by Application (2019-2024)
7.3 Global Alzheimer’s Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Alzheimer’s Therapeutics Sales Growth Rate by Application (2019-2024)
8 Alzheimer’s Therapeutics Market Segmentation by Region
8.1 Global Alzheimer’s Therapeutics Sales by Region
8.1.1 Global Alzheimer’s Therapeutics Sales by Region
8.1.2 Global Alzheimer’s Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Alzheimer’s Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alzheimer’s Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alzheimer’s Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alzheimer’s Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alzheimer’s Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Alzheimer’s Therapeutics Basic Information
9.1.2 Pfizer Alzheimer’s Therapeutics Product Overview
9.1.3 Pfizer Alzheimer’s Therapeutics Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Alzheimer’s Therapeutics SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Merck and
9.2.1 Merck and Alzheimer’s Therapeutics Basic Information
9.2.2 Merck and Alzheimer’s Therapeutics Product Overview
9.2.3 Merck and Alzheimer’s Therapeutics Product Market Performance
9.2.4 Merck and Business Overview
9.2.5 Merck and Alzheimer’s Therapeutics SWOT Analysis
9.2.6 Merck and Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Alzheimer’s Therapeutics Basic Information
9.3.2 Novartis AG Alzheimer’s Therapeutics Product Overview
9.3.3 Novartis AG Alzheimer’s Therapeutics Product Market Performance
9.3.4 Novartis AG Alzheimer’s Therapeutics SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Eisai
9.4.1 Eisai Alzheimer’s Therapeutics Basic Information
9.4.2 Eisai Alzheimer’s Therapeutics Product Overview
9.4.3 Eisai Alzheimer’s Therapeutics Product Market Performance
9.4.4 Eisai Business Overview
9.4.5 Eisai Recent Developments
9.5 H. Lundbeck A/S
9.5.1 H. Lundbeck A/S Alzheimer’s Therapeutics Basic Information
9.5.2 H. Lundbeck A/S Alzheimer’s Therapeutics Product Overview
9.5.3 H. Lundbeck A/S Alzheimer’s Therapeutics Product Market Performance
9.5.4 H. Lundbeck A/S Business Overview
9.5.5 H. Lundbeck A/S Recent Developments
9.6 AC Immune
9.6.1 AC Immune Alzheimer’s Therapeutics Basic Information
9.6.2 AC Immune Alzheimer’s Therapeutics Product Overview
9.6.3 AC Immune Alzheimer’s Therapeutics Product Market Performance
9.6.4 AC Immune Business Overview
9.6.5 AC Immune Recent Developments
9.7 TauRx Pharmaceuticals
9.7.1 TauRx Pharmaceuticals Alzheimer’s Therapeutics Basic Information
9.7.2 TauRx Pharmaceuticals Alzheimer’s Therapeutics Product Overview
9.7.3 TauRx Pharmaceuticals Alzheimer’s Therapeutics Product Market Performance
9.7.4 TauRx Pharmaceuticals Business Overview
9.7.5 TauRx Pharmaceuticals Recent Developments
9.8 Actavis plc.
9.8.1 Actavis plc. Alzheimer’s Therapeutics Basic Information
9.8.2 Actavis plc. Alzheimer’s Therapeutics Product Overview
9.8.3 Actavis plc. Alzheimer’s Therapeutics Product Market Performance
9.8.4 Actavis plc. Business Overview
9.8.5 Actavis plc. Recent Developments
9.9 Forest Laboratories
9.9.1 Forest Laboratories Alzheimer’s Therapeutics Basic Information
9.9.2 Forest Laboratories Alzheimer’s Therapeutics Product Overview
9.9.3 Forest Laboratories Alzheimer’s Therapeutics Product Market Performance
9.9.4 Forest Laboratories Business Overview
9.9.5 Forest Laboratories Recent Developments
9.10 Teva Pharmaceuticals Industries
9.10.1 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Basic Information
9.10.2 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Product Overview
9.10.3 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Product Market Performance
9.10.4 Teva Pharmaceuticals Industries Business Overview
9.10.5 Teva Pharmaceuticals Industries Recent Developments
9.11 Janssen Pharmaceutical
9.11.1 Janssen Pharmaceutical Alzheimer’s Therapeutics Basic Information
9.11.2 Janssen Pharmaceutical Alzheimer’s Therapeutics Product Overview
9.11.3 Janssen Pharmaceutical Alzheimer’s Therapeutics Product Market Performance
9.11.4 Janssen Pharmaceutical Business Overview
9.11.5 Janssen Pharmaceutical Recent Developments
9.12 GE healthcare
9.12.1 GE healthcare Alzheimer’s Therapeutics Basic Information
9.12.2 GE healthcare Alzheimer’s Therapeutics Product Overview
9.12.3 GE healthcare Alzheimer’s Therapeutics Product Market Performance
9.12.4 GE healthcare Business Overview
9.12.5 GE healthcare Recent Developments
9.13 Eli Lilly And Company
9.13.1 Eli Lilly And Company Alzheimer’s Therapeutics Basic Information
9.13.2 Eli Lilly And Company Alzheimer’s Therapeutics Product Overview
9.13.3 Eli Lilly And Company Alzheimer’s Therapeutics Product Market Performance
9.13.4 Eli Lilly And Company Business Overview
9.13.5 Eli Lilly And Company Recent Developments
9.14 DiaGenic ASA
9.14.1 DiaGenic ASA Alzheimer’s Therapeutics Basic Information
9.14.2 DiaGenic ASA Alzheimer’s Therapeutics Product Overview
9.14.3 DiaGenic ASA Alzheimer’s Therapeutics Product Market Performance
9.14.4 DiaGenic ASA Business Overview
9.14.5 DiaGenic ASA Recent Developments
9.15 VTV Therapeutics
9.15.1 VTV Therapeutics Alzheimer’s Therapeutics Basic Information
9.15.2 VTV Therapeutics Alzheimer’s Therapeutics Product Overview
9.15.3 VTV Therapeutics Alzheimer’s Therapeutics Product Market Performance
9.15.4 VTV Therapeutics Business Overview
9.15.5 VTV Therapeutics Recent Developments
9.16 Hoffman-La Roche
9.16.1 Hoffman-La Roche Alzheimer’s Therapeutics Basic Information
9.16.2 Hoffman-La Roche Alzheimer’s Therapeutics Product Overview
9.16.3 Hoffman-La Roche Alzheimer’s Therapeutics Product Market Performance
9.16.4 Hoffman-La Roche Business Overview
9.16.5 Hoffman-La Roche Recent Developments
9.17 AstraZeneca
9.17.1 AstraZeneca Alzheimer’s Therapeutics Basic Information
9.17.2 AstraZeneca Alzheimer’s Therapeutics Product Overview
9.17.3 AstraZeneca Alzheimer’s Therapeutics Product Market Performance
9.17.4 AstraZeneca Business Overview
9.17.5 AstraZeneca Recent Developments
9.18 Daiichi Sankyo Company
9.18.1 Daiichi Sankyo Company Alzheimer’s Therapeutics Basic Information
9.18.2 Daiichi Sankyo Company Alzheimer’s Therapeutics Product Overview
9.18.3 Daiichi Sankyo Company Alzheimer’s Therapeutics Product Market Performance
9.18.4 Daiichi Sankyo Company Business Overview
9.18.5 Daiichi Sankyo Company Recent Developments
10 Alzheimer’s Therapeutics Market Forecast by Region
10.1 Global Alzheimer’s Therapeutics Market Size Forecast
10.2 Global Alzheimer’s Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Alzheimer’s Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Alzheimer’s Therapeutics Market Size Forecast by Region
10.2.4 South America Alzheimer’s Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Alzheimer’s Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Alzheimer’s Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Alzheimer’s Therapeutics by Type (2025-2030)
11.1.2 Global Alzheimer’s Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Alzheimer’s Therapeutics by Type (2025-2030)
11.2 Global Alzheimer’s Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Alzheimer’s Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Alzheimer’s Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings